Invention Grant
- Patent Title: Poly(oxazoline-co-ethyleneimine)-epichlorohydrin copolymers and uses thereof
-
Application No.: US15633999Application Date: 2017-06-27
-
Publication No.: US09910190B2Publication Date: 2018-03-06
- Inventor: Frank Chang , Troy Vernon Holland
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Jian Zhou
- Main IPC: G02B1/10
- IPC: G02B1/10 ; C07D205/04 ; G02B1/04 ; G02C7/04 ; C08G73/02 ; C08J3/24 ; C08G73/06 ; C09D179/02 ; C09D5/00

Abstract:
The invention is related to poly(2-oxazoline-co-ethyleneimine)-epichlorohydrin copolymers and chemically-modified derivatives thereof as well as their uses in formation of non-silicone hydrogel coatings on silicone hydrogel contact lenses.
Public/Granted literature
- US20170293050A1 POLY(OXAZOLINE-CO-ETHYLENEIMINE)-EPICHLOROHYDRIN COPOLYMERS AND USES THEREOF Public/Granted day:2017-10-12
Information query